116 related articles for article (PubMed ID: 28205153)
1. Sociodemographic Disparities in Cure-Intended Treatment in Localized Prostate Cancer.
des Bordes JKA; Lopez DS; Swartz MD; Volk RJ
J Racial Ethn Health Disparities; 2018 Feb; 5(1):104-110. PubMed ID: 28205153
[TBL] [Abstract][Full Text] [Related]
2. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population.
Lichtensztajn DY; Leppert JT; Brooks JD; Shah SA; Sieh W; Chung BI; Gomez SL; Cheng I
J Natl Compr Canc Netw; 2018 Nov; 16(11):1353-1360. PubMed ID: 30442735
[No Abstract] [Full Text] [Related]
3. Racial Differences in Prostate Cancer Treatment: The Role of Socioeconomic Status.
Watson M; Grande D; Radhakrishnan A; Mitra N; Ward KR; Pollack CE
Ethn Dis; 2017; 27(3):201-208. PubMed ID: 28811730
[TBL] [Abstract][Full Text] [Related]
4. The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis.
Oake JD; Harasemiw O; Tangri N; Ferguson TW; Saranchuk JW; Bansal RK; Drachenberg DE; Nayak JG
J Urol; 2021 Nov; 206(5):1204-1211. PubMed ID: 34181467
[TBL] [Abstract][Full Text] [Related]
5. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in californian women after mastectomy.
Hess C; Lee A; Fish K; Daly M; Cress RD; Mayadev J
Clin Breast Cancer; 2015 Jun; 15(3):212-8. PubMed ID: 25499694
[TBL] [Abstract][Full Text] [Related]
7. Patient demographic characteristics and disease stage as drivers of disparities in mortality in prostate cancer patients who receive care at a safety net academic medical center.
Rand AE; Agarwal A; Ahuja D; Ngo T; Qureshi MM; Gupta A; Hirsch AE
Clin Genitourin Cancer; 2014 Dec; 12(6):455-60. PubMed ID: 24998045
[TBL] [Abstract][Full Text] [Related]
8. Marriage and ethnicity predict treatment in localized prostate carcinoma.
Denberg TD; Beaty BL; Kim FJ; Steiner JF
Cancer; 2005 May; 103(9):1819-25. PubMed ID: 15795905
[TBL] [Abstract][Full Text] [Related]
9. Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort.
Wang EH; Yu JB; Abouassally R; Meropol NJ; Cooper G; Shah ND; Williams SB; Gonzalez C; Smaldone MC; Kutikov A; Zhu H; Kim SP
Urology; 2016 Sep; 95():88-94. PubMed ID: 27318264
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
11. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
[TBL] [Abstract][Full Text] [Related]
12. Cancer in relation to socioeconomic status: stage at diagnosis in Texas, 2004-2008.
Risser DR; Miller EA
South Med J; 2012 Oct; 105(10):508-12. PubMed ID: 23038479
[TBL] [Abstract][Full Text] [Related]
13. Treatment of early-stage prostate cancer among rural and urban patients.
Baldwin LM; Andrilla CH; Porter MP; Rosenblatt RA; Patel S; Doescher MP
Cancer; 2013 Aug; 119(16):3067-75. PubMed ID: 23765584
[TBL] [Abstract][Full Text] [Related]
14. Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam.
Bokhorst LP; Kranse R; Venderbos LD; Salman JW; van Leenders GJ; Schröder FH; Bangma CH; Roobol MJ;
Eur Urol; 2015 Aug; 68(2):179-82. PubMed ID: 25457496
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer.
Moses KA; Orom H; Brasel A; Gaddy J; Underwood W
Urol Oncol; 2016 Sep; 34(9):415.e7-415.e12. PubMed ID: 27161898
[TBL] [Abstract][Full Text] [Related]
16. Disparities in the Utilization of Radiation Therapy for Prostate Cancer in the United States: A Comprehensive Review.
Gardner U; McClelland S; Deville C
Adv Radiat Oncol; 2022; 7(4):100943. PubMed ID: 35494548
[TBL] [Abstract][Full Text] [Related]
17. Association of race with receipt of definitive therapy for high risk prostate cancer in older men.
Patel SA; Liu Y; Mahal BA; Jani AB; Sanda MG; Royce TJ; Fischer-Valuck BW
J Geriatr Oncol; 2022 Mar; 13(2):200-206. PubMed ID: 34563484
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.
Harlan LC; Potosky A; Gilliland FD; Hoffman R; Albertsen PC; Hamilton AS; Eley JW; Stanford JL; Stephenson RA
J Natl Cancer Inst; 2001 Dec; 93(24):1864-71. PubMed ID: 11752011
[TBL] [Abstract][Full Text] [Related]
19. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
Liss DT; Baker DW
Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
